Lilly headquarters

Lilly bolsters diagnostics presence with Avid acquisition

November 9, 2010
Research and Development Alzheimer's disease, Alzheimer’s disease, Avid Radiopharma, Eli Lilly, diabetes, emagacestat, florbetapir, lilly

Eli Lilly has acquired specialist diagnostics firm Avid Radiopharma in a deal that will bolster its diagnostics business. Philadelphia-based Avid …

Novartis signs Middle East vaccine production deal

November 9, 2010
Manufacturing and Production Agrippal, Arabio, Novartis, Quinvaxem, meningitis vaccine Menveo, vaccines

Novartis has forged an alliance with a Saudi Arabian manufacturer to help it expand its vaccines business in the Middle …

Cambrex buys Zenara to enter nicotine replacement market

November 9, 2010
API, Cambrex, Cambrex Zenara, India, Pharmaceutical ingredients, Zenara Pharma, generic APIs, nicotine replacement

Pharmaceutical ingredient manufacturer Cambrex has taken a majority stake in Indian formulator Zenara Pharma for $20 million in a move …

Pharma manufacturing news in brief

November 9, 2010
Manufacturing and Production Genentech, Hovione, Jacobs Engineering, Laureate Pharma, Recipharm, contract manufacturing, pharma manufacturing

Hovione wins a patent dispute, Genentech is awarded for a manufacturing plant and there are new contracts for Recipharm, Jacobs …

Late stage trial boost for Pfizer’s arthritis drug tasocitinib

November 8, 2010
JAK inhibitors, Pfizer, arthritis, tasocitinib

Pfizer’s rheumatoid arthritis treatment tasocitinib has met its two of its three primary endpoints in a phase III trial. Primary …

Trial failure for Merck Serono’s Parkinson’s candidate

November 8, 2010
Research and Development Merck Serono, Newron Pharmaceuticals, Parkinson's disease, dopamine agonists, levodopa, safinamide

Merck Serono’s new alpha-aminoamide safinamide has failed to reach its primary endpoint in a study with Parkinson’s disease patients. Merck …

Recycling pharma marketing research

November 8, 2010
Medical Communications, Sales and Marketing Insight Marketing Systems, market research, marketing research, pharma marketing research

Recycling is in vogue. Not just in the consumer market, but across business sectors too. But recycling in the market …

GCI bags Novartis’ social media director

November 8, 2010
Medical Communications GCI Health, Mark Davis, Novartis, appointment, medical communications

Novartis Pharmaceuticals’ former social media director Mark Davis has moved to GCI Health. He has been appointed to lead the …

NICE ‘surprised’ at downgrading of its role

November 5, 2010
Sales and Marketing Andrew Dillon, GP prescribing deicisions, NICE, QALY, incremental cost-effectiveness ratio, value-based pricing

NICE received no warning that its health technology assessment role is to be downgraded, the watchdog’s head has admitted. In …

Roche’s melanoma candidate impresses in phase II trials

November 5, 2010
Research and Development BRAF protein, Cancer, Phase II, Plexxikon, RG7204, Roche

Roche’s mid-stage melanoma candidate has produced positive results in a difficult to treat cancer. RG7204 is an investigational, first-in-class molecule …

Digital health and the Social Network

November 5, 2010
Medical Communications Facebook, Red Door, The Social Network, digital pharma, social media

Followers of film will be only too aware that we are about to embark on ‘Oscar season’. Cinematic features are …

Bayer's Levitra

Bayer faces ABPI audit after “shocking” Levitra error

November 5, 2010
Medical Communications, Sales and Marketing ABPI, ABPI Code of Practice, Bayer, PMCPA

Bayer has been accused of a “shocking error of judgement” after promotional material for its erectile dysfunction brand Levitra (vardenafil) …

Danielle James and Kate Morrison join Virgo

November 5, 2010
Medical Communications Danielle James, Kate Morrison, Virgo, Virgo Health PR, appointment, medical communications

Virgo Health has expanded its medical education and ethical health teams with two new appointments. Danielle James (pictured) has been …

Don’t replace NICE with another ‘misguided experiment’

November 5, 2010
Sales and Marketing NHS, NICE, Stockholm Network, medicines access, risk-sharing

Replacing NICE with a similar system would be detrimental to UK healthcare, according to the Stockholm Network, which further warns …

NicOx to halve HQ workforce

November 4, 2010
Research and Development, Sales and Marketing NicOx, job cuts, naproxcinod, pharma jobs

French pharmaceutical company NicOx is to halve the workforce at its Sophia Antipolis headquarters and is considering restructuring its Italian …

Woolley_Pau_Yvette

Senior creative promotions at Woolley Pau

November 4, 2010
Medical Communications Eric Houseknecht, Woolley Pau, Yvette Cumbers, appointment, medical communications

Woolley Pau has promoted senior copywriter Yvette Cumbers and senior art director Eric Houseknecht to the level of deputy creative …

Doctors.net.uk boosts business development team

November 4, 2010
Sales and Marketing Doctors.net.uk, Jo Bell, Lizzie Evans, Paul Kelly, Phil Oldroyd, appointment, sales and marketing

Online healthcare professional network Doctors.net.uk has made three business development appointments and added a new project manager to its team. …

CME Spotlight: Making European CME work

November 4, 2010
Medical Communications CME, CME Spotlight, Continuing medical education, Eugene Pozniak

Since spring I have been dealing with a team of builders who have missed every deadline possible, to the extent …

Biogen set to axe 650 jobs and focus on neurology

November 4, 2010
Research and Development, Sales and Marketing Biogen, Rituxan, job cuts, pharma jobs

Biogen Idec is set to cut hundreds of jobs and refocus its R&D in an effort to cut costs by …

The Gateway to Local Adoption Series

Latest content